SeaStar Medical Holding Corp (ICU)
0.378
-0.03
(-6.67%)
USD |
NASDAQ |
May 23, 16:00
0.3716
-0.01
(-1.69%)
Pre-Market: 08:23
SeaStar Medical Cash from Operations (TTM): -11.48M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -11.48M |
December 31, 2023 | -10.28M |
September 30, 2023 | -11.10M |
June 30, 2023 | -10.68M |
Date | Value |
---|---|
March 31, 2023 | -9.501M |
December 31, 2022 | -7.794M |
September 30, 2022 | -3.451M |
June 30, 2022 | -4.237M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-11.48M
Minimum
Mar 2024
-3.451M
Maximum
Sep 2022
-8.566M
Average
-9.893M
Median
Cash from Operations (TTM) Benchmarks
Nuwellis Inc | -14.69M |
Ardelyx Inc | -80.64M |
Adverum Biotechnologies Inc | -91.74M |
Aquestive Therapeutics Inc | -25.58M |
Vir Biotechnology Inc | -- |